These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16428145)

  • 1. The use of ciclosporin in psoriasis.
    Berth-Jones J
    J Dermatolog Treat; 2005; 16(5-6):258-77. PubMed ID: 16428145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P; Stevenson O; Berth-Jones J
    Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
    Aydin F; Canturk T; Senturk N; Turanli AY
    Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of ciclosporin in psoriasis: a clinical review.
    Ho VC
    Br J Dermatol; 2004 May; 150 Suppl 67():1-10. PubMed ID: 15115440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciclosporin in psoriasis clinical practice: an international consensus statement.
    Griffiths CE; Dubertret L; Ellis CN; Finlay AY; Finzi AF; Ho VC; Johnston A; Katsambas A; Lison AE; Naeyaert JM; Nakagawa H; Paul C; Vanaclocha F
    Br J Dermatol; 2004 May; 150 Suppl 67():11-23. PubMed ID: 15115441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
    Puig L
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial.
    Flytström I; Stenberg B; Svensson A; Bergbrant IM
    Br J Dermatol; 2008 Jan; 158(1):116-21. PubMed ID: 17986302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A treatment in severe childhood psoriasis.
    Pereira TM; Vieira AP; Fernandes JC; Sousa-Basto A
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):651-6. PubMed ID: 16836490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating clinical activity and gene expression signatures of etanercept and ciclosporin to the psoriasis xenograft SCID mouse model.
    Norsgaard H; Svensson L; Hagedorn PH; Moller K; Olsen GM; Labuda T
    Br J Dermatol; 2012 Mar; 166(3):649-52. PubMed ID: 22050597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
    Sukarovska BG; Lipozencić J; Vrzogić P
    Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ciclosporin].
    Doutre MS
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 1):392-404. PubMed ID: 12055538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis treatment: traditional therapy.
    Lebwohl M; Ting PT; Koo JY
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii83-6. PubMed ID: 15708945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nail psoriasis improvement in a patient treated with fumaric acid esters.
    Vlachou C; Berth-Jones J
    J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of cyclosporin A (CyA) in psoriasis: an overview of dose/response, indications, contraindications and side-effects.
    Zachariae H; Steen Olsen T
    Clin Nephrol; 1995 Mar; 43(3):154-8. PubMed ID: 7774070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of monitoring ciclosporin concentration 2 hours post-dose (C2) in dermatology: a prospective cohort study.
    Chew AL; Bashir SJ; Johnston A; Barker JN; Smith CH
    J Dermatolog Treat; 2011 Apr; 22(2):79-85. PubMed ID: 20673153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience with routine administration of etanercept in psoriasis.
    de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
    Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pustular psoriasis of pregnancy treated with ciclosporin and high-dose prednisolone.
    Edmonds EV; Morris SD; Short K; Bewley SJ; Eady RA
    Clin Exp Dermatol; 2005 Nov; 30(6):709-10. PubMed ID: 16197395
    [No Abstract]   [Full Text] [Related]  

  • 19. Salt sensitivity of blood pressure in patients with psoriasis on ciclosporin therapy.
    Magina S; Santos J; Coroas A; Oliveira JG; Serrão P; Soares-Da-Silva P; Resende C; Pestana M
    Br J Dermatol; 2005 Apr; 152(4):773-6. PubMed ID: 15840112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concepts of the mechanisms of action of cyclosporin in psoriasis. A review with guidelines on therapy].
    Mrowietz U
    Hautarzt; 1993 Jun; 44(6):353-60. PubMed ID: 8392987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.